Long term survival of small cell lung cancer patients after chemotherapy.

Por van der Gaast, A., Postmus, P. E., Burghouts, J., van Bolhuis, C., Stam, J., Splinter, T. A.
Publicado em 1993

Evaluation of a new tumour marker in patients with non-small-cell lung cancer: Cyfra 21.1.

Por van der Gaast, A., Schoenmakers, C. H., Kok, T. C., Blijenberg, B. G., Cornillie, F., Splinter, T. A.
Publicado em 1994

Prognostic value of serum thymidine kinase, tissue polypeptide antigen and neuron specific enolase in patients with small cell lung cancer.

Por van der Gaast, A., van Putten, W. L., Oosterom, R., Cozijnsen, M., Hoekstra, R., Splinter, T. A.
Publicado em 1991

First-line treatment with oxaliplatin and capecitabine in patients with advanced or metastatic oesophageal cancer: a phase II study

Por van Meerten, E, Eskens, F A L M, van Gameren, E C, Doorn, L, van der Gaast, A
Publicado em 2007

Cisplatin and etoposide in oesophageal cancer: a phase II study. Rotterdam Oesophageal Tumour Study Group.

Por Kok, T. C., Van der Gaast, A., Dees, J., Eykenboom, W. M., Van Overhagen, H., Stoter, G., Tilanus, H. W., Splinter, T. A.
Publicado em 1996

Neoadjuvant concurrent chemoradiation with weekly paclitaxel and carboplatin for patients with oesophageal cancer: a phase II study

Por van Meerten, E, Muller, K, Tilanus, H W, Siersema, P D, Eijkenboom, W M H, van Dekken, H, Tran, T C K, van der Gaast, A
Publicado em 2006

The role of socio-economic status in the decision making on diagnosis and treatment of oesophageal cancer in The Netherlands

Por van Vliet, E P M, Eijkemans, M J C, Steyerberg, E W, Kuipers, E J, Tilanus, H W, van der Gaast, A, Siersema, P D
Publicado em 2006

A phase I pharmacokinetic study of the vascular disrupting agent ombrabulin (AVE8062) and docetaxel in advanced solid tumours

Por Eskens, F A L M, Tresca, P, Tosi, D, Van Doorn, L, Fontaine, H, Van der Gaast, A, Veyrat-Follet, C, Oprea, C, Hospitel, M, Dieras, V
Publicado em 2014

Phase II study of bi-weekly administration of paclitaxel and cisplatin in patients with advanced oesophageal cancer

Por Polee, M B, Eskens, F A L M, van der Burg, M E L, Splinter, T A W, Siersema, P D, Tilanus, H W, Verweij, J, Stoter, G, van der Gaast, A
Publicado em 2002

Nurse-led follow-up of patients after oesophageal or gastric cardia cancer surgery: a randomised trial

Por Verschuur, E M L, Steyerberg, E W, Tilanus, H W, Polinder, S, Essink-Bot, M-L, Tran, K T C, van der Gaast, A, Stassen, L P S, Kuipers, E J, Siersema, P D
Publicado em 2009

Phase I and pharmacological study of the broad-spectrum tyrosine kinase inhibitor JNJ-26483327 in patients with advanced solid tumours

Por Konings, I R H M, de Jonge, M J A, Burger, H, van der Gaast, A, van Beijsterveldt, L E C, Winkler, H, Verweij, J, Yuan, Z, Hellemans, P, Eskens, F A L M
Publicado em 2010

Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy

Por Polee, M B, Hop, W C J, Kok, T C, Eskens, F A L M, van der Burg, M E L, Splinter, T A W, Siersema, P D, Tilanus, H W, Stoter, G, van der Gaast, A
Publicado em 2003

Adaptive intrapatient dose escalation of cisplatin in combination with low-dose vp16 in patients with nonsmall cell lung cancer

Por Schellens, J H M, Planting, ASTh, van Zandwijk, N, Ma, J, Maliepaard, M, van der Burg, M E L, de Boer-Dennert, M, Brouwer, E, van der Gaast, A, van den Bent, M J, Verweij, J
Publicado em 2003

Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS)

Por van Heijl, M, van Lanschot, JJB, Koppert, LB, van Berge Henegouwen, MI, Muller, K, Steyerberg, EW, van Dekken, H, Wijnhoven, BPL, Tilanus, HW, Richel, DJ, Busch, ORC, Bartelsman, JF, Koning, CCE, Offerhaus, GJ, van der Gaast, A
Publicado em 2008

Multimodality treatment for esophageal adenocarcinoma: multi-center propensity-score matched study

Por Markar, S. R., Noordman, B. J., Mackenzie, H., Findlay, J. M., Boshier, P. R., Ni, M., Steyerberg, E. W., van der Gaast, A., Hulshof, M. C. C. M., Maynard, N., van Berge Henegouwen, M. I., Wijnhoven, B. P. L., Reynolds, J. V., Van Lanschot, J. J. B., Hanna, G. B.
Publicado no Ann Oncol (2017)